MMRF Logo
1999 Grant Recipients
1999 Senior Research Award Winners

Helen Tighe, PhD
University of California, San Diego
"Immunostimulatory DNA: Application to DNA Based Vaccines for Multiple Myeloma"

Bjarne Bogen, MD, PhD
University of Oslo
"Id-specific T cells in Multiple Myeloma"

William Bellamy, PhD
University of Arizona
"Angiogenic Growth Factors as a Therapeutic Target in Myeloma"

Hyam Levitsky, MD
Johns Hopkins University School of Medicine
"Tumor Vaccines for Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation."

Keith Stockert Goldstein, MD
Stanford University
"Mixed Chimera Transplants Followed by Idiotype Vaccinations for Multiple Myeloma"

Noopur Raje, MD
Dana-Farber Cancer Institute
"The Role of Kaposi's Sarcoma-Associated Virus in Multiple Myeloma Pathogenesis: Oncogenic and Angiogenic Potential of orf72 and orf74"

Leif Bergsagel, MD
Weill Medical College of Cornell University
"Transgenic Mouse Model of Multiple Myeloma"



1999 Fellows' Award Winners
Dharminder Chauhan, PhD
Dana-Farber Cancer Institute
"Interleukin-6 (IL-6) Induced SHP2 Activation Mediates Resistance to Dexamethasone (Dex) &Mac246; Induced RAFTK Activation and Apoptosis in Multiple Myeloma Cells"

Lori Hazlehurst, PhD
H. Lee Moffitt Cancer Center
"The Role of CDK2 in Fibronectin Induced Regulation of p27 Levels"

Babatunde Oyajobi, PhD
Univ. of Texas Health Science Center at San Antonio
"The Role of Macrophage Inflammatory Protein-1 Alpha in the Development of Osteolytic Bone Lesions in Myeloma"

Steven Peter Treon, MD
Dana-Farber Cancer Institute
"Treatment of Multiple Myeloma by Antibody Mediated Immunotherapy and Induction of Tumor Selective Antigens"

Shmuel Yaccoby, PhD
University of Arkansas for MedicalSciences
"Role of the Non-hematopoietic Bone Marrow Stroma in Multiple Myeloma: In Vivo Studies with Primary Myeloma Cells in the SCID-hu Host "